MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2026.1732515

Медицинская библиотека · Frontiers in immunology · 2026

Impact of ALC Nadir and EDRIC on survival outcomes in limited-stage small cell lung cancer receiving chemoradiotherapy: a retrospective analysis comparing twice-daily and once-daily radiotherapy.

Yao Jinquan, Li Yikun, Geng Yuxin, Xu Junhao, Sun Qixin, Huang Baiyang, Zou Bingwen, Sun Xiao, Tang Ning, Teng Feifei

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND

This study aimed to evaluate the prognostic value of absolute lymphocyte count (ALC) nadir and estimated dose of radiation to immune cells (EDRIC) in patients with limited-stage small cell lung cancer (LS-SCLC).

METHODS

This study analyzed 288 patients with LS-SCLC treated with chemoradiotherapy (CRT) between 2019 and 2023. ALC nadir and EDRIC were evaluated for prognostic value across patients receiving twice-daily (BID) and once-daily (QD) radiotherapy. Survival outcomes included overall survival (OS), progression-free survival (PFS), and brain metastasis-free survival (BMFS).

RESULTS

Despite lower lymphocyte counts during early treatment in the BID group, the ALC nadir was significantly higher in the BID group compared with the QD group (median ALC nadir: 0.60 × 109/L vs. 0.49 × 109/L, P < 0.001). In the BID group, patients with ALC nadir > 0.55 × 109/L showed significantly longer OS (median OS: NR vs. 46.7 months, P = 0.011), PFS (P = 0.022), and BMFS (P = 0.013) compared with those with ALC nadir ≤ 0.55 × 109/L. Patients in the high EDRIC group had significantly shorter PFS (P = 0.001) and BMFS (P = 0.003), and a trend toward shorter OS (P = 0.179). In the QD group, no significant differences were observed when stratified by ALC nadir or EDRIC (P > 0.05).

CONCLUSION

ALC nadir and EDRIC demonstrated prognostic significance in the BID group but not in the QD group, suggesting potential differences in radiation-associated immune effects between fractionation schedules.

Для цитирования: Yao Jinquan, Li Yikun, Geng Yuxin, Xu Junhao, Sun Qixin, Huang Baiyang, Zou Bingwen, Sun Xiao, Tang Ning, Teng Feifei. Impact of ALC Nadir and EDRIC on survival outcomes in limited-stage small cell lung cancer receiving chemoradiotherapy: a retrospective analysis comparing twice-daily and once-daily radiotherapy.. Frontiers in immunology. 2026. DOI: 10.3389/fimmu.2026.1732515.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.